Co-Authors
This is a "connection" page, showing publications co-authored by Jesús Rodríguez-Baño and Mario Venditti.
Connection Strength
0.264
-
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum ß-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents. 2018 Nov; 52(5):577-585.
Score: 0.048
-
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort. Clin Infect Dis. 2017 Oct 30; 65(10):1615-1623.
Score: 0.046
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. Int J Antimicrob Agents. 2017 Nov; 50(5):664-672.
Score: 0.045
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017 07; 17(7):726-734.
Score: 0.045
-
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-ß-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2017 03 01; 72(3):906-913.
Score: 0.044
-
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014 Jan; 20 Suppl 1:1-55.
Score: 0.035